Open AccessTreatment of recalcitrant orbital inflammatory syndrome with plasmapheresis therapy
Author(s) -
Yasaira Rodríguez Torres,
Fereshteh Azad,
Xihui Lin
Publication year - 2020
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr-2019-232379
Subject(s) - plasmapheresis , medicine , intensive care medicine , refractory (planetary science) , disease , immunology , physics , astrobiology , antibody
Refractory idiopathic orbital inflammation (IOI) represents a management challenge due to its significant proportion of treatment failures. Currently, there are no established guidelines for recalcitrant IOI and majority of immunosuppressive agents have resulted in variable outcomes. Advancements of plasmapheresis therapy can play a significant role in ophthalmological diseases. This treatment has shown to produce a satisfactory therapeutic response in immune-mediated neurological conditions. In this case report, we share our successful experience with the use of plasmapheresis therapy in a patient with recalcitrant IOI.